SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-323118
Filing Date
2021-11-08
Accepted
2021-11-08 16:43:11
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d238696d8k.htm   iXBRL 8-K 25038
2 EX-99.1 d238696dex991.htm EX-99.1 59542
6 GRAPHIC g238696g1108201547953.jpg GRAPHIC 2316
  Complete submission text file 0001193125-21-323118.txt   222210

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20211108.xsd EX-101.SCH 2897
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20211108_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20211108_pre.xml EX-101.PRE 11863
7 EXTRACTED XBRL INSTANCE DOCUMENT d238696d8k_htm.xml XML 3495
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 211388598
SIC: 2836 Biological Products, (No Diagnostic Substances)